Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant Compared to Timolol Ophthalmic Solution 0.5% Administered Twice Daily in Subjects with Open-Angle Glaucoma or Ocular Hypertension

Inclusion Criteria:

• Diagnosis of open-angle glaucoma or ocular hypertension in the study eye

Exclusion Criteria:

• Prior incisional glaucoma surgery in the study eye
• Prior argon laser trabeculoplasty (ALT) in the study eye
• Prior minimally invasive glaucoma (MIGS) surgery in the study eye